Swiss National Bank
BMY icon

Swiss National Bank’s Bristol-Myers Squibb BMY Stock Holding History

Swiss National Bank’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$362M Buy
5,974,400
+396,700
+7% +$23.1M 0.21% 75
2025
Q4 		$301M Sell
5,577,700
-288,600
-5% -$13.9M 0.18% 91
2025
Q3 		$265M Sell
5,866,300
-293,100
-5% -$13.7M 0.15% 108
2025
Q2 		$285M Buy
6,159,400
+438,900
+8% +$21.5M 0.17% 102
2025
Q1 		$349M Sell
5,720,500
-6,900
-0.1% -$402K 0.25% 72
2024
Q4 		$324M Sell
5,727,400
-289,300
-5% -$16.2M 0.22% 76
2024
Q3 		$311M Buy
6,016,700
+15,900
+0.3% +$746K 0.2% 86
2024
Q2 		$249M Sell
6,000,800
-92,700
-2% -$4.15M 0.17% 99
2024
Q1 		$330M Sell
6,093,500
-439,100
-7% -$22.4M 0.23% 75
2023
Q4 		$335M Sell
6,532,600
-224,700
-3% -$11.8M 0.25% 73
2023
Q3 		$392M Sell
6,757,300
-839,100
-11% -$51.4M 0.31% 53
2023
Q2 		$486M Sell
7,596,400
-841,500
-10% -$56.4M 0.33% 50
2023
Q1 		$585M Sell
8,437,900
-240,400
-3% -$17M 0.4% 45
2022
Q4 		$624M Sell
8,678,300
-548,557
-6% -$41.4M 0.45% 39
2022
Q3 		$656M Sell
9,226,857
-228,400
-2% -$16.6M 0.47% 35
2022
Q2 		$728M Sell
9,455,257
-158,600
-2% -$12.1M 0.49% 36
2022
Q1 		$702M Buy
9,613,857
+1,167,700
+14% +$78.4M 0.4% 47
2021
Q4 		$527M Sell
8,446,157
-387,000
-4% -$22.7M 0.32% 57
2021
Q3 		$523M Sell
8,833,157
-302,600
-3% -$19.9M 0.33% 53
2021
Q2 		$610M Buy
9,135,757
+331,869
+4% +$21.6M 0.38% 49
2021
Q1 		$556M Buy
8,803,888
+180,500
+2% +$11.2M 0.37% 53
2020
Q4 		$535M Sell
8,623,388
-293,700
-3% -$18.1M 0.38% 50
2020
Q3 		$538M Sell
8,917,088
-120,900
-1% -$7.28M 0.42% 45
2020
Q2 		$531M Sell
9,037,988
-175,600
-2% -$10.5M 0.45% 43
2020
Q1 		$514M Buy
9,213,588
+1,718,900
+23% +$105M 0.55% 35
2019
Q4 		$481M Buy
7,494,688
+1,992,824
+36% +$114M 0.49% 33
2019
Q3 		$279M Buy
5,501,864
+81,194
+1% +$3.82M 0.3% 68
2019
Q2 		$246M Sell
5,420,670
-120,100
-2% -$5.59M 0.27% 78
2019
Q1 		$264M Buy
5,540,770
+146,100
+3% +$7.28M 0.29% 71
2018
Q4 		$280M Buy
5,394,670
+85,100
+2% +$4.57M 0.36% 57
2018
Q3 		$330M Sell
5,309,570
-181,600
-3% -$10.8M 0.37% 52
2018
Q2 		$304M Buy
5,491,170
+146,500
+3% +$7.91M 0.35% 58
2018
Q1 		$338M Sell
5,344,670
-787,700
-13% -$50.7M 0.41% 45
2017
Q4 		$376M Buy
6,132,370
+40,900
+0.7% +$2.56M 0.41% 46
2017
Q3 		$388M Sell
6,091,470
-20,100
-0.3% -$1.17M 0.44% 42
2017
Q2 		$341M Buy
6,111,570
+189,900
+3% +$10.3M 0.4% 44
2017
Q1 		$322M Buy
5,921,670
+1,267,900
+27% +$69.5M 0.4% 41
2016
Q4 		$272M Sell
4,653,770
-409,882
-8% -$22.4M 0.43% 39
2016
Q3 		$273M Sell
5,063,652
-62,300
-1% -$4M 0.44% 42
2016
Q2 		$377M Buy
5,125,952
+342,000
+7% +$24.2M 0.61% 29
2016
Q1 		$293M Buy
4,783,952
+1,291,900
+37% +$81.5M 0.54% 33
2015
Q4 		$240M Buy
3,492,052
+59,900
+2% +$3.96M 0.58% 29
2015
Q3 		$203M Buy
3,432,152
+293,600
+9% +$18.6M 0.52% 33
2015
Q2 		$209M Buy
3,138,552
+129,100
+4% +$8.51M 0.54% 29
2015
Q1 		$194M Buy
3,009,452
+938,000
+45% +$58.7M 0.52% 31
2014
Q4 		$122M Sell
2,071,452
-218,100
-10% -$12.3M 0.46% 39
2014
Q3 		$117M Sell
2,289,552
-30,600
-1% -$1.53M 0.45% 43
2014
Q2 		$113M Buy
2,320,152
+18,800
+0.8% +$926K 0.42% 46
2014
Q1 		$120M Sell
2,301,352
-135,200
-6% -$7.19M 0.47% 34
2013
Q4 		$130M Sell
2,436,552
-1,025,800
-30% -$52.3M 0.51% 29
2013
Q3 		$160M Buy
3,462,352
+71,000
+2% +$3.12M 0.67% 19
2013
Q2 		$152M Buy
+3,391,352
New +$147M 0.67% 19

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Swiss National Bank's BMY Position: Q1 2026 in Review

Swiss National Bank increased its Bristol-Myers Squibb (BMY) stake by 7.1% in Q1 2026, buying an estimated $23.1M and bringing the position to 5,974,400 shares worth $362M. The position accounts for 0.21% of the portfolio, ranked #75.

Swiss National Bank first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $728M in Q2 2022. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Swiss National Bank held 5,974,400 shares of Bristol-Myers Squibb worth $362M as of Q1 2026.
  • Swiss National Bank bought 396,700 Bristol-Myers Squibb shares in Q1 2026, an estimated $23.1M.
  • Bristol-Myers Squibb made up 0.21% of Swiss National Bank's portfolio in Q1 2026, its #75 holding.
  • Swiss National Bank first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
  • Swiss National Bank's Bristol-Myers Squibb position peaked at $728M in Q2 2022.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Swiss National Bank's 13F filing for Q1 2026, filed 7 May 2026.